Abstract: Protein models can be of great assistance in functional genomics, as they provide the structural insights often necessary to understand protein function. Although comparative modelling is far from yielding perfect structures, this is still the most reliable method and the quality of the predictions is now well understood. Models can be classified according to their correctness and accuracy, which will impact their applicability and usefulness in functional genomics and a variety of situations.
INTRODUCTION
Understanding the function and the physiological role of proteins is a fundamental requirement for the discovery of novel medicines (small molecules) and 'biologicals' (protein-based products) with medical, industrial or commodity applications. Although the draft sequence of the complete human genome has been published, humankind is very far from understanding the function and the physiological role of the gene products it encodes. Indeed, being able to read the letters and the words is disconnected from understanding their meaning. Therefore, the attention of many biologists is now focusing on the functional analysis of the genome.
The term 'functional analysis' however, merits a few short comments as one can easily distinguish three levels of gene-related knowledge. Firstly, one should not forget that a gene can encode several transcripts. Indeed, genes can have several splice products yielding as many raw protein transcripts. Then, each transcript can be further altered by post-transcriptional modifications, which can be context specific (such as cell type or cell cycle stage). Secondly, proteins will have a basic biochemical function, which in many cases can be attributed by analogy with well studied family members. However, in most cases, it is necessary to confirm these inferred functions through experimental approaches. By doing so, the knowledge base on protein will grow and functional predictions will become increasingly precise. Thirdly, the physiological role of a protein has to be defined, meaning that the precise role of the protein in physiological processes has to be uncovered. This is a higher level of knowledge than the function. Indeed, one can know the precise activity of an enzyme, including well worked-out reaction kinetics, but not understand how it contributes to the processes of life. This is very frequent, as one still discovers new roles for well studied proteins. The 'full picture' will thus take a very long time before it takes shape and represent the ultimate grand challenge in biology.
Functional analysis requires the application of a combination of very diverse technologies. Most of these are aimed at producing data and information using experimental ('wet') approaches in vitro or in vivo, while others will generate models and hypothesis using in silico methods. These models and hypothesis will serve as guides during experimental planing. Protein structure determination, is one of those areas of biology where both experimental and theoretical approaches have made a lot of progress in recent years and are complementing each other.
A protein's function is tightly linked to its three dimensional (3D) structure. As residues located far apart in the primary sequence can be very close in space, and only a few residues are generally responsible for a protein's function, insights into the 3D structure of a protein can represent a key component of the functional analysis process. Consequently, an atomic level 3D representation to assign roles to specific residues is a major asset, both for planning experiments and explaining observations. The 'folding' process of a protein is very complex and no objective and reliable way to determine it from the sole sequence has as yet been developed. The scientific community is thus dependent on experimental protein structure elucidation. The usual approaches, both x-ray diffraction and NMR, are, however, both hampered by technical hurdles and limitations. Consequently several concerted 'Structural Genomics' efforts have been launched in both private and public sectors. These efforts will address these difficulties and increase the throughput of experimental structure elucidation. These will, however, not be sufficient to elucidate the structure of all proteins of interest. Today the protein sequence databases SWISS-PROT and trEMBL contain approximately 50 times more protein se-quences than there are known 3D structures. The direct consequences of this is that only the 'highly interesting' proteins will be elucidated experimentally in the foreseeable future.
In this context, comparative modelling methods (homology based) have been developed and have matured to a point where many of the resulting models yield enough, insights into a protein's 3D structure to be useful in functional analysis.
The following contribution is not intended as a review of the field but much rather as a few personal views on protein modelling and its application largely based on the author's own experience.
WHAT IS COMPARATIVE PROTEIN MODELLING?
Proteins from different sources and sometimes diverse biological functions can have similar sequences, and it is generally accepted that high sequence similarity is reflected by distinct structure similarity. Indeed, the root mean square deviation (rmsd) of the alpha-carbon coordinates for protein cores sharing 50% residue identity is expected to be around 1Å (Chothia and Lesk, 1986) . Thus the most reliable prediction methods, termed comparative protein modelling (also often called modelling by homology), consist of the extrapolation of the structure for a new (target) sequence from the known 3D structure of related family members (templates) (Bajorath et al., 1993) .
IDENTIFICATION OF MODELLING TEMPLATES
Comparative protein modelling requires at least one sequence of known 3D structure with significant similarity to the target sequence. In order to determine if a modelling request can be carried out, one generally compares the target sequence with a database of sequences derived from the Brookhaven Protein Data Bank (PDB). This can be performed using any sequence similarity search algorithm. For a given target sequence, this procedure often allows the selection of more than one suitable modelling template. In some cases, although this is by far not a general rule, multiple templates can help improve the resulting models. In our hands, however, there is no statistically relevant correlation between the number of templates used during model building and the overall quality of a model (as assessed during the 3D crunch experiment). In this case, the template structure sharing the highest sequence similarity with the target should serve as the reference onto which the other selected templates must be optimally superposed (in 3D). As a result, each residue of the reference structure is then aligned with a residue from the other available templates. This yields a structurally corrected multiple sequence alignment.
ALIGNING THE TARGET SEQUENCE WITH THE TEMPLATE SEQUENCE(S)
The target sequence can then be aligned with the template sequence or, if several templates were selected, with the structurally corrected multiple sequence alignment using the best-scoring diagonals obtained by sequence alignment algorithms such as SIM (Huang and Miller, 1991) . Residues, which should not be used for model building, for example those located in non-conserved loops, will be ignored during the modelling process. Thus, the common core of the target protein and the loops completely defined by at least one supplied template structure will be built.
As discussed below, the sequence alignment guiding the modelling procedure is a crucial component of the overall process and the quality of the resulting models depends on it to a large extend. Therefore a high level of attention should be given to this step. It is generally accepted that the use of additional sequences (without known 3D structure) of the same protein family, selected to represent the sequence diversity within that family, can markedly improve the multiple sequence alignment. Such additional sequences can obviously be found by searching database such as SWISS-PROT and trEMBL using BLAST and their relative alignment can be found in protein family databases such as PFAM. Furthermore, it should be noted that manual adjustments are often the most powerful way to create corrected alignments where no algorithm is available.
BUILDING THE MODEL
The co-ordinates of the model can then be built. The (multiple) sequence alignment serves as a 'correspondence table' between target sequence and template structures from which a weight averaged structural framework can be derived. This framework can then be completed by the addition of lacking or incomplete loop structures-which correspond to insertion and deletions in the sequence alignment-the rebuilding of undefined backbone atoms, the correction of ill-defined side chain geometries and the addition of lacking side chains.
MODEL REFINEMENT
The final step of the co-ordinate generation process in the idealization of stereochemistry of the model, and consists mainly of the optimization of bond geometry and the removal of unfavourable non-bonded contacts. This step can be performed by energy minimization packages such as CHARMM (Brooks et al., 1983) or GROMOS (van Gunsteren et al., 1996) .
Excessive energy minimization will cause the model to deviate markedly from the original model, which is not suitable and should be avoided. Indeed, experience has shown that the changes induced by force field computations do not improved the accuracy of the model with respect to a control experimental structure (Moult, 1999) . Thus, one should keep the number of minimization cycles to a minimum, but sufficient to improve the stereochemistry of the model.
ASSESSING THE MODEL QUALITY
The quality of a model is determined by two distinct criteria, which will determine its applicability. First, the correctness of a model is dictated by the quality of the sequence alignment used to guide the modelling process. If the sequence alignment is wrong in some regions, then the spatial arrangement of the residues in this portion of the model will be incorrect. The first edition of the community-wide experiment known as Critical Assessment of protein Structure Prediction (CASP) already underscored that most severe modelling errors can be traced back to sequence alignment mistakes. (Mosimann et al., 1995) . This remains, despite many efforts to address this issue, the main weakness of comparative protein modelling.
Second, the accuracy of a model is essentially limited by the deviation of the used template structure(s) relative to the experimental control structure. This limitation is inherent to the methods used, since models result from an extrapolation. As a consequence, the core Ca atoms of protein models which share 35 to 50% sequence identity with their templates, will generally deviate by 1.0 to 1.5Å from their experimental counter parts as do experimentally elucidated structures (Chothia and Lesk, 1986) . One should however not overlook the contributions of the templates to the model accuracy. The templates, which are obtained through experimental approaches, are subject to structural variations not only caused by experimental errors and differences in data collection conditions-such as the temperature (Tilton et al., 1992) , but also because of different crystal lattice contacts and the presence or absence of ligands. Almost every protein model based on templates with a sequence similarity below 40% contains non-conserved loops, which are expected to be the least reliable portions of a protein model. Indeed, non-conserved loops generally deviate markedly from experimentally determined control structures. In many cases, however, these loops also correspond to the most flexible parts of the structure as evidenced by their high crystallographic temperature factors (or multiple solutions in NMR experiments). On the other hand, the core residues-the least variable in any given protein familyare usually found in essentially the same orientation as in experimental control structures, while far larger deviations are observed for surface amino acids. This is expected since the core residues are generally well conserved and the rotamers of their side chains are constrained by neighbouring residues. In contrast, the more variable surface amino acids will tend to show more deviations since there are few steric constraints imposed upon them.
Some structural aspects of a protein model can be verified using methods based on fold recognition methods. These methods rely on empirical pseudo-conformational energy potentials derived from the pair-wise interactions observed in well defined protein structures. These terms are summed over all residues in a model and result in a more (more negative) or less (more positive) favourable energy. These methods can detect a global sequence to structure incompatibility and errors corresponding to topological differences between template and target. They also allow the detection of more localized errors such as bstrands that are 'out of register' or buried charged residues. However, none of these methods has allowed the detection of the more subtle structural inconsistencies, which are often localized in non-conserved loops, and can thus not provide an assessment of the correctness of their geometry.
ABOUT THE USE OF PROTEIN MODELS
The protein model obtained with comparative modelling methods can be broadly classified into three categories: (i) models which are based on incorrect alignments between target and template sequences. Such alignment errors, which generally reside in the inaccurate positioning of insertions and deletions, are caused by the weaknesses of the alignment algorithms and can often not be resolved in the absence of a control experimental structure. It is however often possible to correct such errors by producing several models based on several alignment variants and by selecting the most 'sensible' solution. In some cases, this selection process can be guided by methods based on empirical pair potentials such as threading. This is however not always the case, and one should be careful to interpret the results of these methods with care. Nevertheless, it turns out that such models are often useful as the errors are not systematically located in the area of interest, such as within a well conserved active site. (ii) Models based on correct alignments are of course much better, but their accuracy can still be medium to low as the templates used during the modelling process have a medium to low sequence similarity with the target sequence. Such models, as the ones described above, are, however, very useful tools for the rational mutagenesis experiment design and molecular replacement in crystallography (Sanchez et al., 2000) . They can, however, not be of great assistance during detailed ligand binding studies. (iii) The last category of models comprises all those which were build based on templates which share a high degree of sequence identity (>70%) with the target. Such models have proven useful during drug design projects and allowed the taking of key decisions in compound optimization and chemical synthesis (Sanchez et al., 2000) . For instance, models of several species variants of a given enzyme can guide the design of more specific non-natural inhibitors.
However, nothing is absolute and there are numerous occasions in which models falling in any of the above categories, could either not be used at all or in contrast proved to be more useful and correct as first assessed.
In our experience, several applications of medium-to high-accuracy models have proven successful. These can be broadly classified into three categories:
Interpreting the impact of mutations on protein function. Potential link to diseases One of the first uses one can make of a model structure is to interpret the impact a mutation can have on the overall structure and thus function of a protein. Although the development of objective scoring functions has begun only recently, 'visual inspection' associated with a good knowledge and understanding of the rules underlying protein structure has proven useful in defining the broad reasons for mutant malfunction (for concrete examples see Hahne et al., 1995; Notarangelo et al., 1996; Lalioti et al., 1997) . While these mutations can be produced experimentally, in which case the model will be used to interpret experimental results, there is an increasingly large body of data on naturally occurring mutations (over 8000 human sequence variants are reported in SWISS-PROT) and single nucleotide polymorphisms (SNP), of which a sizeable proportion will alter the translated protein sequences. Interpreting the potential functional effects of these mutants will be crucial to elucidate the molecular basis of human diseases.
Prioritisation of residues to mutate to determine protein function As mentioned in the introduction, the discovery of gene function in the genomic era will require a sustained experimental effort, which includes the creation of molecular mutants. The prioritization of residues to mutate will be greatly optimized by considering the 3D structure of the target protein Schneider et al., 1997) . In many cases, one is then able to predict the nature of the change. These predictions can then in be interpreted in the light of the model (see above).
Providing hints for protein function
This is probably the broadest and least defined spectrum of potential applications for 3D models. The common feature of these applications is that models can be used to formulate a hypothesis around a protein, which can then be tested in experimental settings. For instance, one can use them to identify potential enzymatic activities (Peitsch and Boguski, 1991) and possible ligand binding functions (Peitsch and Boguski, 1990) . Models can also be used to confirm a hypothesis derived from sequence analysis alone. Indeed, low degrees of sequence similarity are not necessarily sufficient to attribute a functional class to a protein. In such cases, protein modelling can help determine or confirm an assignment (Duret et al., 1998) .
A generally accepted limitation of protein models (versus experimental structures) is their applicability to drug design. This is probably more of a perception that the truth, especially if one considers models for what they can provide. In our experience (unpublished observations), models of species variants of a protein, which is the target for a novel antibiotic, have proven very useful to understand the species-dependent efficacy of certain compounds. The pharmaceutical industry increasingly utilizes protein models during drug design programs, especially in the early phases, until such time the model is replaced by an experimentally elucidated structure, often obtained in presence of the bound compound.
MODELLING MEMBRANE PROTEINS
Membrane proteins still remain a class of proteins that represent a great challenge to modellers. G-protein coupled receptors in particular, also represent a group of molecules of special interest to the pharmaceutical industry as a very large proportion of today's medicines are modulators of their activities. Modelling such proteins has thus been attempted in many occasions and both de novo and comparative approaches have been used. The two main steps along the path to a model have been automated: (i) algorithms have been developed to identify the transmembrane domains and (ii) to generate 3D models using de novo approaches and comparative methods. The resulting models are generally of medium to low accuracy and should thus be used with a lot of caution. They are however of great assistance during experimental design (mutagenesis). More recently, experimental structures of the potassium channel (Doyle et al., 1998) and rhodopsin A have been elucidated (Palczewski et al., 2000) , allowing for true homology modelling work to be performed in these protein families.
